Since bladder cancer is the 10th most common cancer worldwide, early detection and accurate screening are crucial
2022-11-01
Since bladder cancer is one of the 10 most common cancer worldwide, early detection and accurate screening are crucial.
Read about the risks associated with this hidden killer and how liquid biopsies constitute a new, non-invasive, #DNA-powered tool enabling more efficient and cost-effective early diagnosis.
 - 1.png)
 - 2.png)
 - 3.png)
 - 4.png)
About BGI Genomics
BGI Genomics, headquartered in Shenzhen China, is the world’s leading integrated solutions provider of precision medicine. Our services cover more than 100 countries and regions, involving more than 2,300 medical institutions. In July of 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.